1. Yan, Yuze, Tian, Miaomiao, Li, Meng, Liu, Shiguo, Guan, Ji-Song. 2022. ASH1L haploinsufficiency results in autistic-like phenotypes in mice and links Eph receptor gene to autism spectrum disorder. In Neuron, 110, 1156-1172.e9. doi:10.1016/j.neuron.2021.12.035. https://pubmed.ncbi.nlm.nih.gov/35081333/
2. Shaker, Olfat G, Ayeldeen, Ghada, Abdelhamid, Amr M. 2020. Circulating microRNA-944 and its target gene EPHA7 as a potential biomarker for colorectal cancer. In Archives of physiology and biochemistry, 128, 1181-1187. doi:10.1080/13813455.2020.1762658. https://pubmed.ncbi.nlm.nih.gov/32421395/
3. Wang, Li, Zhao, Qiao-Feng, Yang, Bing-Bing, Tian, Fang, Wu, Qing-Hua. 2023. STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma. In Acta oncologica (Stockholm, Sweden), 62, 1757-1766. doi:10.1080/0284186X.2023.2259601. https://pubmed.ncbi.nlm.nih.gov/37738252/
4. López-Nieva, Pilar, Vaquero, Concepción, Fernández-Navarro, Pablo, Esteller, Manel, Fernández-Piqueras, José. 2011. EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas. In Carcinogenesis, 33, 452-8. doi:10.1093/carcin/bgr271. https://pubmed.ncbi.nlm.nih.gov/22114070/
5. Zhang, Zhen, Wu, Hao-Xiang, Lin, Wu-Hao, Zeng, Zhao-Lei, Luo, Hui-Yan. 2021. EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers. In BMC medicine, 19, 26. doi:10.1186/s12916-020-01899-x. https://pubmed.ncbi.nlm.nih.gov/33526018/
智鼠故事 
